Results 231 to 240 of about 425,993 (391)

Imbalance of IL-1β and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis [PDF]

, 1999
Laura Gramantieri, A.M. Casali, Davide Treré, Silvia Gaiani, Fabio Piscaglia, Pasquale Chieco, Bruno Cola, Luigi Bolondi   +7 more
openalex   +1 more source

Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer

Alimentary Pharmacology &Therapeutics, EarlyView.
In a cohort of 1596 liver cancer patients with either current or prior HBV infection undergoing systemic therapy in Hong Kong, the risk of HBV reactivation during immune checkpoint inhibitor treatment was low when adequate antiviral prophylaxis was administered, irrespective of HBV infection status.
Dorothy Cheuk‐Yan Yiu, Jimmy Che‐To Lai, Landon Long Chan, Grace Lai‐Hung Wong, Mandy Sze‐Man Lai, Vincent Wai‐Sun Wong, Yee‐Kit Tse, Henry Lik‐Yuen Chan, Stephen Lam Chan, Terry Cheuk‐Fung Yip   +9 more
wiley   +1 more source

Antibody against hepatitis C virus(HCV) in hemophiliacs and in human plasma preparation products.

, 1990
Susumu Okubo, Manabu Yamaoka, Keiko Okayama, Tomoko Ishida, Kōjirō Yasunaga   +4 more
openalex   +2 more sources

Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

Alimentary Pharmacology &Therapeutics, EarlyView.
In a multi‐centre study of obeticholic acid in primary biliary cholangitis, 45% discontinued the drug over 4 years, with 11% moving to combination therapy (fibrates). Of those continuing, response rates increased from 37% (1 year) to 55% (4 years). Non‐response at 12 months and cirrhosis were independent predictors of liver‐related events.
Nadir Abbas, Rachel Smith, Ellina Lytvyak, Miki Scaravaglio, Neil Halliday, Amal Almahroos, Nadia Eden, Diane Lloyd‐Madden, Sanchit Sharma, James Ferguson, Jessica K. Dyson, Douglas Thorburn, David Jones, Aldo J. Montano‐Loza, Marco Carbone, Pietro Invernizzi, George Mells, Emma L. Culver, Palak J. Trivedi   +18 more
wiley   +1 more source

Differences among specialists in using the Electronic Medical Record alert system for HCV screening in outpatients at a large general hospital. [PDF]

PLoS One
Lin CK, Peng YS, Yang CY.
europepmc   +1 more source

Change of anti-HCV antibody titer during interferon therapy. Investigation of NS3, NS4 and core region antibody.

, 1993
Yoshiyasu Karino, Syuhei Hige, Akiyoshi Saga, T Matsushima, Tamotsu Miyazaki, Jyoji Toyota, Yutaka Okuuchi   +6 more
openalex   +2 more sources

Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection [PDF]

, 1998
B. Kallinowski, K Haseroth, George Marinos, Christoph Hanck, Wolfgang Stremmel, Lorenz Theilmann, Manfred V. Singer, S. Rossol   +7 more
openalex   +1 more source

Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.

New England Journal of Medicine, 2017
David S. Goldberg, Peter L. Abt, Emily A. Blumberg, V. V. Van Deerlin, M. Levine, K. Rajender Reddy, Roy D. Bloom, Susanna M. Nazarian, D. Sawinski, P. Porrett, A. Naji, R. Hasz, Lawrence Suplee, J. Trofe‐Clark, A. Sicilia, M. McCauley, M. Farooqi, C. Gentile, Jennifer R. Smith, Peter P. Reese   +19 more
semanticscholar   +1 more source

Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease

Alimentary Pharmacology &Therapeutics, EarlyView.
Extracellular matrix (ECM) remodelling biomarkers reflect portal hypertension and disease severity in advanced chronic liver disease (ACLD). However, their predictive value for disease progression is largely restricted to compensated ACLD (cACLD). ABSTRACT Background Extracellular matrix (ECM) remodelling in advanced chronic liver disease (ACLD) is ...
Benedikt Simbrunner, Ida Falk Villesen, Georg Semmler, Lorenz Balcar, Georg Kramer, Joana Almeida Calvão, Benedikt Silvester Hofer, Mathias Jachs, Lukas Hartl, Jurij Maurer, Bernhard Scheiner, Kerstin Zinober, Rodrig Marculescu, Michael Trauner, Morten Karsdal, Thomas Reiberger, Mattias Mandorfer, Diana Julie Leeming   +17 more
wiley   +1 more source

Rising drug overdose deaths in chronic liver disease in the United States, 2015–2023 [PDF]

Clinical and Molecular Hepatology
Donghee Kim, Brittany B Dennis, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed   +5 more
doaj   +1 more source